MPL – Credit Suisse rates the stock as Downgrade to Underperform from Neutral

By Broker News | More Articles by Broker News

Credit Suisse finds considerable uncertainty prevails for FY20 and FY21 earnings and does not envisage much upside for the share price. The broker finds listed health insurers expensive.

Private health insurance profit growth has been slowing recently, driven by a slowdown in premium growth and a stabilising of the margin.

Hence, the broker downgrades to Underperform from Neutral. The main risks to the negative view are acquisitions, funded from the debt-free balance sheet. Target is steady at $2.50.

Sector: Insurance.

Target price is $2.50.Current Price is $2.71. Difference: ($0.21) – (brackets indicate current price is over target). If MPL meets the Credit Suisse target it will return approximately -8% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →